Apomorphine and dopamine D1 receptor agonists increase the firing rates of subthalamic nucleus neurons

Neuroscience

Volumn 72, Issue 3, 1996, Pages 863-876

  Kreiss, D S ^a,b   Anderson, L A ^a   Walters, J R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES   (United States)

Author keywords

autoradiography; basal ganglia; electrophysiology; SKF 38393; SKF 82958

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; CHLORAL HYDRATE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; KETAMINE; QUINPIROLE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; ELECTROPHYSIOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SUBTHALAMIC NUCLEUS; TOPICAL DRUG ADMINISTRATION;

EID: 0030003650     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00583-8     Document Type: Article

References (95)

1. Abarca J., Gysling K., Roth R. H. and Bustos G. (1995) Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies. Neurochem. Res. 20, 159-169.
2. Afsharpour S. (1985) Topographical projections of the cerebral cortex to the subthalamic nucleus. J. comp. Neurol. 236, 14-28.
3. Albin R. L., Young A. B. and Penney J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375.
4. 1 receptor efficacy. Eur. J. Pharmac. 188, 335-347.
5. Aziz T. Z., Peggs D., Sambrook M. A. and Crossman A. R. (1991) Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism in the primate. Mov. Disord. 6, 288-292.
6. Benabid A. L., Pollak P., Gross C., Hoffmann D., Benazzouz A., Gao D. M., Laurent A., Gentil M. and Perret J. (1994) Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's Disease. Stereotact. Funct. Neurosurg. 62, 76-84.
7. Benazzouz A., Gross C., Féger J., Boraud T. and Bioulac B. (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci. 5, 382-389.
8. Bergman H., Wichmann T. and DeLong M. R. (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249, 1436-1438.
9. Bergman H., Wichman T., Karmon B. and DeLong M. R. (1994) The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism. J. Neurophysiol. 72, 507-520.
10. Bergstrom D. A., Bromley S. D. and Walters J. R. (1982) Apomorphine increases the activity of rat globus pallidus neurons. Brain Res. 238, 266-271.
11. Bergstrom D. A., Bromley S. D. and Walters J. R. (1984) Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesia. Eur. J. Pharmac. 100, 3-12.
12. Bernardi G., Marciani M. G., Morocutti C., Pavone F. and Stanzione P. (1978) The action of dopamine on rat caudate neurons intracellularly recorded. Neurosci. Lett. 8, 235-240.
13. 125I] iodosulpride. Neuroscience 20, 117-155.
14. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6, 3177-3188.
15. Brown L. L., Makman M. H., Wolfson L. I., Dvorkin B., Warner C. and Katzman R. (1979) A direct role of dopamine in the rat subthalamic nucleus and an adjacent intrapeduncular area. Science 266, 1416-1418.
16. Brown L. L. and Wolfson L. I. (1978) Apomorphine increases glucose utilization in the substantia nigra, subthalamic nucleus, and corpus striatum of rat. Brain Res. 140, 188-193.
17. Campbell G. A., Eckhardt M. J. and Weight F. F. (1985) Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis. Brain Res. 333, 261-270.
18. Canteras N. S., Shammah-Lagnado S. J., Silva B. A. and Ricardo J. A. (1990) Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 513, 43-59.
19. Carlsson M. and Carlsson A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13, 272-276.
20. Carpenter M. B., Carleton S. C., Keller J. T. and Conte P. (1981) Connections of the subthalamic nucleus in the monkey. Brain Res. 224, 1-29.
21. Carpenter M. B., Whittier J. R. and Mettler F. A. (1950) Analysis of choreoid hyperkinesia in the rhesus monkey. J. comp. Neurol. 92, 293-332.
22. Chevalier G. and Deniau J. M. (1990) Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci. 13, 277-280.
23. 2-agonist LY171555. J. Cardiovasc. Pharmac. 6, 1245-1248.
24. Crossman A. R. (1987) Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Neuroscience 21, 1-40.
25. Crossman A. R., Sambrook M. A. and Jackson A. (1984) Experimental hemichorea/hemiballismus in the monkey. Brain 107, 579-596.
26. 1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand. Neuroscience 26, 83-100.
27. DeLong M. R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285.
28. 2 dopamine receptors. Neuroscience 19, 125-137.
29. Féger J., Mouroux M., Benazzouz A., Boraud T., Gross C. and Crossman A. R. (1994) The subthalamic nucleus: a more complex structure than expected. In The Basal Ganglia IV: New Ideas and Data on Structure and Function (ed. Percheron G.), pp. 371-382. Plenum Press, New York.
30. 1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. natn Acad. Sci. U.S.A. 88, 3772-3776.
31. Fujimoto K. and Kita H. (1993) Response characteristics of subthalamic neurons to the stimulation of the sensorimotor cortex in the rat. Brain Res. 609, 185-192.
32. Groenewegen H. J. and Berenise H. W. (1990) Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat. J. comp. Neurol. 294, 607-622.
33. Guridi J., Luquin M. R., Herrero M. T. and Obeso J. A. (1993) The subthalamic nucleus, a possible target for stereotaxic surgery in Parkinson's Disease. Mov. Disord. 8, 421-429.
34. Hamada I. and DeLong M. R. (1992) Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs. J. Neurophysiol. 68, 1850-1858.
35. Hammond C., Deniau J. M., Rouzaire-Dubois B. and Féger J. (1978) Peripheral input to the rat subthalamic nucleus: an electrophysiological study. Neurosci. Lett. 9, 171-176.
36. Hammond C., Féger J., Bioulac B. and Souteyrand J. P. (1979) Experimental hemiballism in the monkey produced by unilateral kainic acid lesion in corpus Luysii, Brain Res. 171, 577-580.
37. Hökfelt T., Ljungdahl A., Fuxe K. and Johansson O. (1974) Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. Science 184, 177-179.
38. Hollerman J. R. and Grace A. A. (1992) Subthalamic nucleus cell firing in the 6-hydroxydopamine-treated rat: basal activity and response to haloperidol. Brain Res. 590, 291-298.
39. 1 dopamine receptor modulation of basal ganglia output. J. Pharmac. exp. Ther. 271, 1434-1443.
40. 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro. Life Sci. 23, 551-556.
41. Hyttel J. (1983) SCH 23390 - the first selective dopamine D-1 antagonist. Eur. J. Pharmac. 91, 153-154.
42. Iorio L. C., Barnett A., Leitz F. H., Houser V. P. and Korduba C. A. (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmac. exp. Ther. 226, 462-468.
43. Jackson A. and Crossman A. R. (1981) Subthalamic nucleus efferent projection to the cerebral cortex. Neuroscience 6, 2367-2377.
44. Johnson A. E., Coirini H., Kallstrom L. and Wiesel F. A. (1994) Characterization of dopamine receptor binding sites in the subthalamic nucleus. NeuroReport 5, 1836-1838.
45. 1 receptors modulate glutamate transmission in the ventral tegmental area. J. Neurosci. 15, 5379-5388.
46. Kelland M. D., Soltis R. P., Anderson L. A., Bergstrom D. A. and Walters J. R. (1995) In vivo characterization of two cell types in the rat globus pallidus which have opposite responses to dopamine receptor stimulation: comparison of electrophysiological properties and responses to apomorphine, dizocilpine and ketamine anesthesia. Synapse 20, 338-350.
47. Kelley A. E., Delfs J. M. and Chu B. (1990) Neurotoxicity induced by the D-1 agonist SKF 38393 following microinjection into rat brain. Brain Res. 532, 342-346.
48. Kita H., Chang H. T. and Kitai S. T. (1983) The morphology of intracellularly labeled rat subthalamic neurons: a light microscopic analysis. J. comp. Neurol. 215, 245-257.
49. Kita H. and Kitai S. T. (1987) Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J. comp. Neurol. 260, 435-452.
50. Kitai S. T. and Deniau J. M. (1981) Cortical inputs to the subthalamus: intracellular analysis. Brain Res. 214, 411-415.
51. IA autoreceptors of the dorsal and median raphe nuclei. J. Pharmac. exp. Ther. 269, 1268-1279.
52. 2 receptor binding sites. Molec. Pharmac. 21, 301-314.
53. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Le Bas J. F., Broussolle E., Perret J. E. and Benabid A. L. (1995) Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 354, 91-95.
54. Lindvall O. and Björklund A. (1974) The organization of the ascending catecholamine neuron systems in the rat brain as revealed by glyoxylic acid fluorescence method. Acta Physiol. scand. Suppl. 412, 1-48.
55. 1 receptor binding and mRNA in rat brain using receptor autoradiography and in situ hybridization techniques. Neuroscience 46, 959-971.
56. 125I]iodosulpride, a highly selective ligand. Science 228, 752-755.
57. Martin J. P. (1927) Hemichorea resulting from a local lesion of the brain. Brain 50, 637-651.
58. Meibach R. C. and Katzman R. (1979) Catecholaminergic innervation of the subthalamic nucleus: evidence for a rostral continuation of the A9 (substantia nigra) dopaminergic cell group. Brain Res. 173, 364-368.
59. 1 receptor family agonists, SK&F 38393, SK&F 77434, and SK&F 82958, differentially affect locomotor activities in rats. Pharmac. Biochem. Behav. 46, 269-274.
60. Millan M. H., Patel S., Mello L. M. and Meldrum B. S. (1986) Focal injection of 2-amino-7-phosphonoheptane acid into prepiriform cortex protects against pilocarpine-induced limbic seizures in rats. Neurosci. Lett. 70, 69-74.
61. Miller W. C. and DeLong M. R. (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of Parkinsonism. In The Basal Ganglia II. Structure and Function (eds Carpenter M. B. and Jayaraman A.), Vol. 32, pp. 415-427. Plenum Press, New York.
62. Mintz I., Hammond C. and Féger J. (1986) Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus. Brain Res. 375, 172-175.
63. Mitchell I. J., Boyce S., Sambrook M. A. and Crossman A. R. (1992) A 2-deoxyglucose study of the effects of dopamine agonists on the Parkinsonian primate brain. Brain 115, 809-824.
64. Mitchell I. J., Brotchie J. M., Graham W. C., Page R. D., Robertson R. G., Sambrook M. A. and Crossman A. R. (1989) In Basal Ganglia III. Advances in the Understanding of Neuronal Mechanisms in Movement Disorders (eds Bernardi G., Carpenter M. B., Di Chiara G., Morelli M. and Stanzione P.), pp. 607-616. Plenum Press, New York.
65. Mitchell I. J., Jackson A., Sambrook M. A. and Crossman A. R. (1989) The role of the subthalamic nucleus in experimental chorea. Brain 112, 1533-1548.
66. Myers R. D. (1966) Injection of solutions into cerebral tissue, relation between volume and diffusion. Physiol. Behav. 1, 171-174.
67. 2 receptor agonist, in the conscious rat. J. Pharmac. exp. Ther. 236, 735-743.
68. 1 dopamine receptor. Neuropharmacology 28, 401-405.
69. 2 dopamine receptors. Eur. J. Pharmac. 98, 433-436.
70. Pan H. S., Engber T. M., Chase T. N. and Walters J. R. (1990) The effects of striatal lesion on turning behavior and globus pallidus single unit response to dopamine agonist administration. Life Sci. 46, 73-80.
71. Pan H. S., Penney J. B. and Young A. B. (1985) γ-Aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J. Neurochem. 45, 1396-1404.
72. Parent A. and Smith Y. (1987) Organization of efferent projections of the subthalamic nucleus in the squirrel monkey as revealed by retrograde labeling methods. Brain Res. 436, 296-310.
73. Parry T. J., Eberle-Wang K., Lucki I. and Chesselet M. F. (1994) Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesa in rats. Exp. Neurol. 128, 181-190.
74. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Florida.
75. Pfeiffer F. R., Wilson J. W., Weinstock J., Kuo G. Y., Chambers P. A., Holden K. G., Hahn R. A., Wardell J. R., Tobia A. J., Setler P. E. and Sarau H. M. (1982) Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines. J. med. Chem. 25, 352-358.
76. Robledo P. and Féger J. (1991) Acute monoaminergic depletion in the rat potentiates the excitatory effects of the subthalamic nucleus in the substantia nigra pars reticulata but not in the pallidal complex. J. neural Transm. 86, 115-126.
77. Rouzaire-Dubois B., Hammond C., Hamon B. and Féger J. (1980) Pharmacological blockade of the globus pallidus-induced inhibitory response of subthalamic cells in the rat. Brain Res. 200, 321-329.
78. Rouzaire-Dubois B. and Scarnati E. (1987) Pharmacological study of the cortical-induced excitation of subthalamic nucleus neurons in the rat: evidence for amino acids as putative neurotransmitters. Neuroscience 21, 429-440.
79. Ryan L. J., Sanders D. J. and Clark K. B. (1992) Auto-and cross-correlation analysis of subthalamic nucleus neuronal activity in neostriatal-and globus pallidal-lesioned rats. Brain Res. 583, 253-261.
80. 3H]SCH 23390. Brain Res. 375, 291-301.
81. Sibley D. R., Leff S. E. and Creese I. (1982) Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors. Life Sci. 31, 637-645.
82. Sibley D. R. and Monsma F. J. (1992) Molecular biology of dopamine receptors. Trends Neurosci. 13, 61-69.
83. Smith Y., Bolam J. P. and von Krosigk M. (1990) Topographical and synaptic organization of the GABA-containing pallidosubthalamic projection in the rat. Eur. J. Neurosci. 2, 500-511.
84. 1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation. Brain Res. 607, 270-274.
85. Twery M. J., Thompson L. A. and Walters J. R. (1994) Intracellularly recorded response of rat striatal neurons in vitro to fenoldopam and SKF 38393 following lesions of midbrain dopamine cells. Synapse 18, 67-78.
86. Versteeg D. H. G., VanDer Guten J., De Jong W. and Palkovits M. (1976) Regional concentrations of noradrenaline and dopamine in rat brain. Brain Res. 113, 563-574.
87. 2 agonist effects. Science 236, 719-722.
88. Walters J. R., Bergstrom D. A., Carlson J. H., Weick B. G. and Pan H. S. (1987) Stimulation of D-1 and D-2 dopamine receptors: synergistic effects on single unit activity in basal ganglia output nuclei. In Neurophysiology of Dopaminergic Systems - Current Status and Clinical Perspectives (eds Chiodo L. A. and Freeman A. S.), pp. 285-316. Lakeshore, Detroit, MI.
89. Wamsley J. K., Gehlert D. R., Filloux F. M. and Dawson T. M. (1989) Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain. J. Chem. Neuroanat. 2, 119-137.
90. Waszczak B. L., Lee E. K., Ferraro T., Hare T. A. and Walters J. R. (1984) Single unit responses of substantia nigra pars reticulata neurons to apomorphine: effects of striatal lesions and anesthesia. Brain Res. 306, 307-318.
91. Wechsler L. R., Savaki H. E. and Sokoloff L. (1979) Effects of D-and L-amphetamine on local cerebral glucose utilization in the conscious rat. J. Neurochem. 32, 15-22.
92. 2 coactivation induces potentiated responses. Brain Res. 405, 234-246.
93. Whittier J. R. (1947) Ballism and the subthalamic nucleus (nucleus hypothalamicus; corpus Luysi). Arch. Neurol. Psychiat. 58, 672-692.
94. Whittier J. R. and Mettler F. A. (1949) Studies on the subthalamic nucleus of the rhesus monkey. II. Hyperkinesia and other physiologic effects of subthalamic lesions, with special reference to the subthalamic nucleus of Luys. J. comp. Neurol. 90, 319-372.
95. Yamamura T., Harada K., Okamura A. and Kemmotsu O. (1990) Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor? Anesthesiology 72, 704-710.